Skip to main content
Log in

Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris

  • New Antimicrobial Agents
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The antibacterial activity of the topical quinolone OPC-7251 against bacteria commonly found in acne vulgaris was tested in vitro by an agar dilution method. The MIC50 was 0.25 mg/l forPropionibacterium acnes, 0.125 mg/l forPropionibacterium granulosum, 0.03 mg/l forStaphylococcus aureus and 0.06 mg/l for coagulase-negative staphylococci. Compared with seven other antibiotics tested (ciprofloxacin, penicillin, erythromycin, tetracycline, clindamycin, fusidic acid and gentamicin), OPC-7251 had potent activity against both propionibacteria and staphylococci and the lowest incidence of resistant strains.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Leeming JP, Holland KT, Cunliffe WJ The microbial colonization of inflamed acne vulgaris lesions. British Journal of Dermatology 1988, 118: 203–208.

    Google Scholar 

  2. Cunliffe WJ Microbiology of acne. In: Cunliffe WJ (ed): Acne. Martin Dunitz, London, 1989, p. 178–210.

    Google Scholar 

  3. Gollnick H, Zouboulis CC, Akamatsu H, Kurokawa I, Schulte A Pathogenesis and pathogenesis related treatment of acne. Journal of Dermatology 1991, 18: 489–499.

    Google Scholar 

  4. Eady EA, Cove JH, Holland KT, Cunliffe WJ Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. British Journal of Dermatology 1989, 121: 51–57.

    Google Scholar 

  5. Kawabata S, Ohguro K, Mukai F, Ohmori K, Miyamoto H, Tamaoka H Bacteriological evaluation of OPC-7251, a new pyridone carboxylic acid antimicrobial agent. 1: In vitro antibacterial activity. Japanese Journal of Chemotherapy 1989, 37: 1160–1178.

    Google Scholar 

  6. Kawabata S, Masada H, Wakebe H, Ohmori K, Tamaoka H Bacteriological evaluation of OPG-7251, a new pyridone carboxylic acid antimicrobial agent. 2: Therapeutic effect of OPC-7251 cream on experimental infection model in mice. Japanese Journal of Chemotherapy 1989, 37: 1179–1183.

    Google Scholar 

  7. Kurokawa I, Akamatsu H, Nishijima S, Asada Y, Kawabata S Clinical and bacteriological evaluation of OPC-7251 in patients with acne: a double-blind group comparison study versus cream base. Journal of the American Academy of Dermatology 1991, 25: 674–681.

    Google Scholar 

  8. Lee WL, Shalita AR, Suntharalingam K, Fikrig SM Neutrophil chemotaxis byPropionibacterium acnes lipase and its inhibition. Infection and Immunity 1982, 35: 71–78.

    Google Scholar 

  9. Eady EA, Holland KT, Cunliffe WJ The use of antibiotics in acne therapy: oral or topical administration? Journal of Antimicrobial Chemotherapy 1982, 10: 89–115.

    Google Scholar 

  10. Eady EA, Ross JI, Cove JH, Holland KT, Cunliffe WJ The effects of oral erythromycin therapy for acne on the development of resistance in cutaneous staphylococci and propionibacteria. In: Marks R, Plewig G (ed): Acne and related disorders. Martin Dunitz, London, 1989, p. 265–270.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vogt, K., Hermann, J., Blume, U. et al. Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris. Eur. J. Clin. Microbiol. Infect. Dis. 11, 943–945 (1992). https://doi.org/10.1007/BF01962381

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01962381

Keywords

Navigation